Gabapentin Capsule
Product Images NDC 67296-2299

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 67296-2299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Equation Of Cockcroft And Gault (Gabapentin Fig1)

A text panel displaying the formula for calculating creatinine clearance (CLCr), which involves age in years, weight in kilograms, serum creatinine in mg/dL, and a correction factor of 0.85 for female patients.*

FDA Label Image

Fig-2 (Gabapentin Fig2)

A line graph depicting mean pain scores over an 8-week period, comparing placebo and Gabapentin at 3600 mg/day. The x-axis shows weeks from baseline to 8, while the y-axis represents mean pain score ranging from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period, with Gabapentin showing a decline in pain scores compared to relatively stable scores for placebo.*

FDA Label Image

Fig-3 (Gabapentin Fig3)

Line graph illustrating mean pain scores over a 7-week period, comparing placebo and Gabapentin at dosages of 1800 mg/day and 2400 mg/day. The timeline is divided into a 3-week dose titration period followed by a 4-week fixed dose period, with pain scores on the vertical axis and weeks on the horizontal axis.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig4)

A bar chart comparing two studies showing percentage values on the Y-axis ranging from 0% to 100%. Study 1 compares PBO (placebo) at 12% to GBP 3600 at 29%. Study 2 compares PBO at 14% with GBP 1800 at 32% and GBP 2400 at 34%. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig5)

A scatter plot displaying percentage difference on the y-axis and daily dose in milligrams on the x-axis. The plot compares three studies (a, b, and c) with data points marked in black, dark gray, and light gray squares respectively. Doses range from 600 mg to 1800 mg with corresponding differences from about 7% to 18%.*

FDA Label Image

Package Label-principal Display Panel (100 mg (100 Capsules Bottle))

Label for Gabapentin Capsules, USP 100 mg by NorthStar, containing 100 capsules. The label includes prescribing information, storage instructions, manufacturer details, and a barcode. It notes the drug is Rx only and provides medication guide contact info. The label also cites manufacture in India by APL Healthcare Limited.*

FDA Label Image

Package Label-principal Display Panel (300 mg (100 Capsules Bottle))

Label for NorthStar Gabapentin Capsules, USP 300 mg, containing 100 capsules. The label includes dosage instructions, storage conditions (20° to 25°C), and manufacturer information for Northstar Rx LLC and APL Healthcare Limited. It features the NDC 16714-662-01 and directs users to a pharmacist for medication guides.*

FDA Label Image

Package Label-principal Display Panel (400 mg (100 Capsules Bottle))

Label for Gabapentin Capsules USP 400 mg, containing 100 capsules. The label includes dosage information, storage instructions, and contact details for medication guides. Manufactured for Northstar Rx LLC, Memphis, TN, and by APL Healthcare Limited, India. The label features the NorthStar logo and a barcode.*

FDA Label Image

Chemical Structure (Gabapentin Str)

Chemical structure diagram of Gabapentin, showing its molecular composition with a cyclohexane ring bonded to an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.